Intercellular adhesion molecule-1 suppression in skin by topical delivery of anti-sense oligonucleotides

Journal of Investigative Dermatology

Volumn 115, Issue 5, 2000, Pages 805-812

  Mehta, R C ^a   Stecker, K K ^a   Cooper, S R ^a   Templin, M V ^a   Tsai, Y J ^a   Condon, T P ^a   Bennett, C F ^a   Hardee, G E ^a  

^a ISIS PHARMACEUTICALS   (United States)

Author keywords

Drug delivery; Psoriasis

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; INTERCELLULAR ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENE REPRESSION; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN TISSUE; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN GRAFT;

EID: 0033749825     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00143.x     Document Type: Article

References (47)

1. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris
2. Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells
3. Anti-sense oligonucleotide therapeutics
4. ICAM-1 anti-sense oligonucleotides
5. Inhibition of endothelial cell adhesion molecule expression with anti-sense oligonucleotides
6. An ICAM-1 anti-sense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice
7. The pathogenesis of psoriasis: Immunological facts and speculations
8. Cellular distribution of phosphorothioate oligodeoxynucleotides in normal rodent tissues
9. Anti-sense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms
10. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
11. Experimental production and modulation of human cytotoxic dermatitis in human-murine chimeras
12. Progress in anti-sense oligonucleotide therapeutics
13. Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7
14. Differential expression of ICAM-1, E-selectin and VCAM-1 by endothelial cells in psoriasis and contact dermatitis
15. Cyclosporin therapy in psoriasis: Recommendations for treatment. Italian Multicenter Study Group on Cyclosporin in Psoriasis
16. Psoriasis after allogeneic bone marrow transplantation
17. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis
18. Treatment of psoriasis
19. Novel therapeutic approaches to psoriasis
20. Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: Modulation by recombinant gamma interferon and tumor necrosis factor
21. Role of the intercellular adhesion molecule-1 (ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 anti-sense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice
22. Description of the intrafollicular delivery of large molecular weight molecules to follicles of human scale skin in vitro
23. Intercellular adhesion molecule-I (ICAM-I) expression correlated to inflammation
24. Enhanced metastatic ability of TNFα-treated malignant melanoma cells is reduced by intercellular adhesion molecule-1 (ICAM-1, CD54) anti-sense oligonucleotides
25. Cyclosporin A for psoriasis
26. Cationic lipid is not required for uptake and selective inhibitory activity of ICAM-1 phosphorothioate anti-sense oligonucleotides in keratinocytes
27. The cytokine network in psoriasis
28. Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis
29. Accessory cell function of keratinocytes for superantigens. Dependence on lymphocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction
30. Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: Detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161
31. Percutaneous penetration of methyl phosphonate anti-sense oligonucleotides
32. The development of manifest psoriatic lesions is linked with the appearance of ICAM-1 positivity on keratinocytes
33. ELAM-1 is an adhesion molecule for skin-homing T cells
34. Reduced contact sensitivity reactions in mice treated with monoclonal antibodies to leukocyte function-associated molecule-1 and intercellular adhesion molecule-1
35. A co-stimulatory signal through ICAM-beta2 integrin-binding potentiates neutrophil phagocytosis
36. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
37. Does anti-sense exist?
38. Phosphorothioate anti-sense oligodeoxynucleotides: Questions of specificity
39. Blocking of heart allograft rejection by intercellular adhesion molecule-1 anti-sense oligonucleotides alone or in combination with other immunosuppressive modalities
40. Protection against allograft rejection with intercellular adhesion molecule-1 anti-sense oligodeoxynucleotides
41. Gene inhibition using anti-sense oligodeoxynucleotides
42. Live confocal microscopy of oligonucleotide uptake by keratinocytes in human skin grafts on nude mice
43. Dermal injection of immunocytes induces psoriasis
44. A placebo-controlled trial of ICAM-1 anti-sense oligonucleotide in the treatment of Crohn's disease
45. Human/severe combined immunodeficient mouse chimeras. An experimental in vivo model system to study the regulation of human endothelial cell-leukocyte adhesion molecules
46. Pharmacokinetics and tissue disposition in monkeys of an antisense oligonucleotide inhibitor of ha-ras encapsulated in stealth liposomes